Adsorbent capable of reducing in vivo urotoxin
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JINGYUN BIOLOGICAL TECH SHANGHAI
- Publication Date
- 2015-06-03
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to an oral substance for treating or preventing kidney diseases, in particular to an adsorbent capable of reducing uremic toxins in the body, which is used for reducing uremic toxins in individuals and slowing down the deterioration of renal function. Background technique
[0002] The metabolic wastes excreted by the kidneys are commonly called urea toxins, and the concentration of urea toxins in serum can be used as an indicator of renal function. A uremic toxin: indoxyl sulfate (indoxyl sulfate) is considered to be one of the main causes of exacerbation of chronic kidney disease. The production process of indoxyl sulfate is that the bacteria in the intestine metabolize the tryptophan (Tryptophan) ingested from food into indole (Indole), and indole is metabolized into indoxyl sulfate in the liver, and then excreted through the kidneys. When renal function declines, indoxyl sulfate and other urea toxins, such as creatinin...